ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL1201831
CHEMBL1201831
Compound Name CERTOLIZUMAB PEGOL
ChEMBL Synonyms CIMZIA | PHA-738144 | CDP-870 | CERTOLIZUMAB PEGOL
Max Phase 4 (Approved)
Trade Names CIMZIA

Sources

  • British National Formulary
  • Clinical Candidates
  • Manually Added Drugs
  • USP Dictionary of USAN and International Drug Names
  • WHO Anatomical Therapeutic Chemical Classification

Molecule Features

CHEMBL1201831 compound icon
Drug Type:Antibody Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:Y Topical:N Black Box:Y Availability Type:Prescription-only

Mechanism of Action

Mechanism of Action ChEMBL Target References
TNF-alpha inhibitor TNF-alpha DailyMed

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Colitis, UlcerativeD003093EFO:0000729ulcerative colitis2ClinicalTrials
Crohn DiseaseD003424EFO:0000384Crohn's disease4ClinicalTrials
DailyMed
Arthritis, PsoriaticD015535EFO:0003778psoriatic arthritis4DailyMed
Immune System DiseasesD007154EFO:0000540immune system disease4ATC
PsoriasisD011565EFO:0000676psoriasis3ClinicalTrials
Spondylitis, AnkylosingD013167EFO:0003898ankylosing spondylitis4ClinicalTrials
DailyMed
Arthritis, RheumatoidD001172EFO:0000685rheumatoid arthritis4ClinicalTrials
DailyMed
MelanomaD008545EFO:0000756melanoma1ClinicalTrials
Arthritis, JuvenileD001171EFO:0002609chronic childhood arthritis3ClinicalTrials
Cystitis, InterstitialD018856EFO:1000869chronic interstitial cystitis3ClinicalTrials

Clinical Data

ClinicalTrials.gov CERTOLIZUMAB PEGOL
The Cochrane Collaboration CERTOLIZUMAB PEGOL

Compound Cross References

ATC L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 - IMMUNOSUPPRESSANTS
L04A - IMMUNOSUPPRESSANTS
L04AB - Tumor necrosis factor alpha (TNF-α) inhibitors
L04AB05 - certolizumab pegol

ChemSpider ChemSpider Identifier not yet assigned
DailyMed certolizumab pegol
Wikipedia Certolizumab_pegol
spacer
spacer